KAL1 antibody (AA 131-230) (Cy7)
Quick Overview for KAL1 antibody (AA 131-230) (Cy7) (ABIN1406880)
Target
See all KAL1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 131-230
-
Predicted Reactivity
- Human,Rat,Dog,Sheep,Pig,Horse,Chicken
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Anosmin-1
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- KAL1 (Kallmann Syndrome 1 Sequence (KAL1))
-
Alternative Name
- Anosmin 1
-
Background
-
Synonyms: KAL, Adhesion molecule-like X-linked, ADMLX, Anosmin-1, HHA, KAL1, KALIG 1, KALIG1, Kallmann syndrome 1 sequence anosmin 1, Kallmann syndrome interval gene 1, Kallmann syndrome protein, KALM, KALM_HUMAN, KMS.
Background: May be an adhesion-like molecule with anti-protease activity.
Target
-